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Primary renal carcinoid tumors are exceedingly rare, with less than 100 total cases being documented in
world literature. A 32-year old male was referred to our service for a slow-growing, renal mass, which
was ﬁrst diagnosed 9-years prior. The patient was successfully treated with radical nephrectomy. In this
article, we present our case report on an asymptomatic primary renal carcinoid tumor.
 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Primary carcinoid tumors of the kidney are extremely rare
neoplasms, with less than 100 cases being documented in world
literature. Therefore, not much is known about the pathogenesis and
prognosis of these tumors. Carcinoid tumors are low-grade,malignant
neoplasms, which most classically present within the gastrointestinal
tract and lungs.1 The purpose of this article is to present our clinical
workup and surgical intervention of this rare urological neoplasm.Case presentation
A 32-year old male presented as a urology consult for a right
kidney mass. He has a signiﬁcant past medical history of recurrent
nephrolithiasis without surgical intervention. During imaging of
the kidney stones, a right kidney mass was incidentally found. The
lesion had at least doubled in size since it was ﬁrst diagnosed
9-years ago. He denies gross hematuria and lower urinary tract
symptoms. He also denies ﬂank pain, abdominal pain, fevers, chills,
or unintentional weight loss. He denies any family history of
urologic malignancies. He has a 7.5 pack/year smoking history. CT
scan reveals that the mass is solid and enhancing, measuring
3.8  3.9  3.5 cm (Fig. 1). At the patient’s request, a PET-CT fusion
test was ordered, which showed normal FDG uptake in the right
kidney mass, and no abnormal FDG uptake throughout the body.
Given the enlarging size and the probability that this was a
cancerous mass, the patient elected to undergo robotic assisted
laparoscopic right radical nephrectomy. After the kidney had been).
Inc. This is an open access article uremoved in surgery, several nodal packets were observed along the
lateral margin of the cava. Therefore, a paracaval lymph node
dissection (2.5 cm) was also performed. Pathological analysis
revealed that the mass was a 5.0  5.0  4.0 poorly circumscribed,
friable tumor thatﬁlled the renal sinus and adjacent tissue. Themass
was pushing into the helium, andwas less than 0.1 cm from the fatty
margin. All margins were negative. Microscopic analysis revealed
the neoplastic cells to have tall columnar cytoplasmwith a uniform
oval nucleus. There were not any mitoses observed. The neoplastic
cells were strongly positive for chromogranin and synaptophysin
(Figs. 2 and 3). The cells were negative for cytokeratin 7, cytokeratin
20, and prostate speciﬁc antigen. The proliferationmarker Ki-67was
positive in less than2%of thenuclei. Extensive sectioningof the right
kidney revealed focal invasion into the capsule, with a few nests of
tumors found in the fat outside of the capsule. These are described as
“ﬂoaters” and not “true” invasive carcinoma. This was therefore
determined tobeaprimarycarcinoid tumorbypathological analysis.
Furthermore, the right paracaval lymph node was found to have
been replaced microscopically by malignant neoplasm. The staging
was determined to be pT3aN1.
After the nephrectomy, the recommendations by the oncology
service were to manage this disease similarly to a regular carcinoid
tumor without carcinoid syndrome. In this case, we would monitor
him with urine and blood tests done at regular intervals checking
speciﬁcally for serotonin and chromogranin A. Upon 1-month
follow-up, both the chromogranin A and serotonin levels were
within normal ranges.
Discussion
Carcinoid tumors have been described by Zuetenhorst et al as
neuroendocrine tumors that are derived from neurochromafﬁnnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. Posterior medial interlobar lesion that has close proximity to the hilum
without vascular invasion.
Figure 3. Resected tumor slide showing chromogranin positivity.
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carcinoid tumors are classically only symptomatic if their lesion
produces vasoactive peptides (producing ﬂushing, diarrhea,
wheezing, etc.).2 The patient described here was without any
symptoms, and the renal carcinoid only being found due to
the imaging for his kidney stones. According to Omiyale et al, 25e
30% of primary renal carcinoid tumors are found incidentally. Other
commonly reported symptoms are abdominal/ﬂank pain, hematu-
ria, constipation, urinary frequency, fever, weight loss, epigastric
discomfort, and abdominal mass on physical exam.3 It should be
noted that within the documented cases, neuroendocrine
syndromes are rare, with the incidence being 12.7%.3
The majority of renal carcinoid tumors described in the litera-
ture are histologically analogous to carcinoids found elsewhere,
featuring low mitotic activity, without necrosis, and arranged in a
trabecular pattern with a nested pattern.3 The origin of the renal
carcinoid tumor is of debate, given that neuroendocrine cells are
not found in normal renal parenchyma. It has been proposed thatFigure 2. Resected tumor slide showing synaptophysin positivity.the tumor has an embryologic association, with the tumor being
derived from misplaced neural crest cells in the kidney’s hilum.1
The carcinoid described in this case showed no necrosis, no
mitoses, and a proliferation marker Ki-67 positivity in less than 2%
of cells. Therefore, our case can be considered a typical carcinoid.
According to Omiyale et al, the only predictive prognostic measure
of these tumors is staging. However, survival rates are excellent,
with 73.1% of patients without evidence of disease after treatment.3Conclusion
Due to the rarity of published data on renal carcinoid tumors, it
is difﬁcult assess their prognosis. It has been shown that renal
carcinoid tumors are more common in patients with horseshoe
kidney, with a 62-fold increase in relative risk.4 In understanding
the indolent nature of carcinoid tumors of the kidney, it is well
within reason that our patient’s lesion could have started even
greater than 9-years ago.Consent
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